TORONTO, July 3, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE) is pleased to provide an update on the progress of the joint venture between its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma) and Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly”).
CHILD-BRIGHT Network and Ehave Start Enrollment for Cognitive Rehabilitation Trial for Children with ADHD, Autism, and Congenital Heart Disease
OAKVILLE, Ontario, June 28, 2018 /PRNewswire/ — The CHILD-BRIGHT Network, a Canadian patient-oriented research network focussed on pediatric brain-based developmental disorders, and Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the mental health community with next-generation digital solutions, today announced the start of enrollment for the CHILD-BRIGHT Mega Team research project trial, a Canadian-developed video game-based cognitive intervention that aims to improve executive functions in children with brain-based developmental disabilities such as Attention Deficit and Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), or born with a Congenital Heart Defect (CHD).
Canada House Wellness Group’s Licensed Cannabis Producer Abba Medix Receives First Sales License from Health Canada
TORONTO, July 23, 2018 (GLOBE NEWSWIRE) — Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that its wholly owned subsidiary, Abba Medix Corp. (“Abba”), a licensed cannabis producer under the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) has successfully completed its Health Canada pre-sales inspection and has received an amendment to its Producer’s Licence from Health Canada to include the sale and provision of marihuana seeds, effective July 20, 2018.
FSD Pharma Inc. Welcomes Official Passing of Cannabis Act in Canada
TORONTO, June 22, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), welcomes the official passing of Bill C-45, the Cannabis Act in Canada.
Continue Reading “FSD Pharma Inc. Welcomes Official Passing of Cannabis Act in Canada”
FSD Pharma Inc. Announces Appointment of Chief Commercial Officer
TORONTO, June 21, 2018 /CNW/ – Thomas Fairfull, President and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”) (CSE:HUGE), is pleased to announce the appointment of Mr. Michael Ash as the Chief Commercial Officer of FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of the Company.
Continue Reading “FSD Pharma Inc. Announces Appointment of Chief Commercial Officer”
FSD Pharma Inc. Announces a Partnership Agreement with Cannara Biotech Inc. to Allow for Indoor Grow Space to Increase to a Combined 1,245,000 Square Feet
TORONTO, June 19, 2018 /CNW/ – FSD Pharma Inc. (“FSD Pharma” or “The Company”) (CSE:HUGE), announced the signing of a partnership agreement between FV Pharma Inc. (“FV Pharma”), a wholly-owned subsidiary of the Company, and Cannara Biotech Inc. (“Cannara”) effective May 31, 2018. The agreement creates the ability for the Company to become the largest indoor medical cannabis growing operation in North America. Together, FV Pharma and Cannara have a combined floor space of over 1.245 million square feet of indoor growing capacity.
NuRAN Wireless and Avanti Communications Sign Partnership Agreement
QUEBEC CITY, June 19, 2018 (GLOBE NEWSWIRE) — NuRAN Wireless Inc. (“NuRAN Wireless” or the “Company”) (CSE:NUR) (OTC:NRRWF) (FSE:1RN) is pleased to announce that it has signed an MOU with Avanti Communications Group plc (“Avanti”), [AIM (AVN:LSE)] to market and distribute a combined 2G RAN product alongside Avanti’s Ka-band satellite backhaul solution.
Continue Reading “NuRAN Wireless and Avanti Communications Sign Partnership Agreement”
FSD Pharma Inc. Commences Trading on Canadian Securities Exchange
TORONTO, May 29, 2018 /CNW/ – FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE), a Canadian cannabis company focused on building the world’s largest indoor hydroponic cultivation and processing facility through its wholly owned subsidiary FV Pharma Inc. (“FV”), a Licensed Producer (“LP”) pursuant to the Access to Cannabis for Medical Purposes Regulations (“ACMPR”), is pleased to announce the company has commenced trading publicly on the Canadian Securities Exchange (“CSE”) under the symbol “HUGE”.
Continue Reading “FSD Pharma Inc. Commences Trading on Canadian Securities Exchange”
Mission Ready Announces Proposed Name Change
VANCOUVER, British Columbia, May 25, 2018 (GLOBE NEWSWIRE) — Mission Ready Services Inc. (“Mission Ready” or the “Company”) (TSXV:MRS) announces that the Company proposes to change its name from Mission Ready Services Inc. to Mission Ready Solutions Inc.
Continue Reading “Mission Ready Announces Proposed Name Change”
High Tide Closes Private Placement over $3.7 Million including Strategic Investment by FV Pharma
CALGARY, May 2, 2018 /CNW/ – High Tide Ventures Inc. (“High Tide” or the “Company”) today announced that it has completed and closed a non-brokered private placement offering (the “Offering”), pursuant to which the Company issued 3,705,000 common shares at a price of $1.00 per share for gross proceeds of $3,705,000. Among the investors participating in the Offering was FV Pharma Inc., a licensed producer that is working with Cannabis Wheaton Income Corp. (TSX.V:CBW) to develop the world’s largest hydroponic indoor cannabis cultivation facility in Cobourg, Ontario.